ducovest

GEHC:NSD-GE HealthCare Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 86.58

Change

0.00 (0.00)%

Market Cap

USD 39.59B

Volume

4.08M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Company Website : https://www.gehealthcare.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-09 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
HQY HealthEquity Inc

N/A

 USD 9.51B
TEM Tempus AI, Inc. Class A Common..

N/A

 USD 9.00B
WAY Waystar Holding Corp. Common S..

N/A

 USD 4.47B
BTSG BrightSpring Health Services, ..

N/A

 USD 3.36B
PRVA Privia Health Group Inc

N/A

 USD 2.72B
PINC Premier Inc

N/A

 USD 1.93B
CERT Certara Inc

N/A

 USD 1.93B
GDRX Goodrx Holdings Inc

N/A

 USD 1.91B
SDGR Schrodinger Inc

N/A

 USD 1.87B
OMCL Omnicell Inc

N/A

 USD 1.78B

ETFs Containing GEHC

OCFS Professionally Managed Po.. 5.34 % 0.00 %

N/A

 USD 8.84M
XYLU:LSE Global X S&P 500® Covere.. 4.39 % 0.00 %

N/A

 USD 0.07B
UMDV:SW iShares US Medical Device.. 2.94 % 0.00 %

N/A

 N/A
MOTV:LSE VanEck Morningstar US Wid.. 2.60 % 0.00 %

N/A

 USD 0.06B
MOTU:LSE VanEck Morningstar US Wid.. 2.59 % 0.00 %

N/A

 USD 0.06B
XGSD:SW Xtrackers Stoxx Global Se.. 2.58 % 0.00 %

N/A

 USD 0.70B
XGSD:XETRA Xtrackers Stoxx Global Se.. 2.58 % 0.00 %

N/A

 N/A
RSPH Invesco S&P 500 Equal Wei.. 1.82 % 0.00 %

N/A

 USD 0.83B
CSD Invesco S&P Spin-Off ETF 0.00 % 1.16 %

N/A

 N/A
CSD Invesco S&P Spin-Off ETF 0.00 % 0.61 %

N/A

 N/A
IHI iShares U.S. Medical Devi.. 0.00 % 0.43 %

N/A

 N/A
QQXT First Trust NASDAQ-100 Ex.. 0.00 % 0.60 %

N/A

 USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.74% 80% B- 85% B
Dividend Return 0.04% 33% F 1% F
Total Return 10.79% 80% B- 85% B
Trailing 12 Months  
Capital Gain -7.77% 63% D 45% F
Dividend Return 0.13% 11% F 1% F
Total Return -7.63% 63% D 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.00% 72% C 57% F
Dividend Return 7.05% 70% C- 54% F
Total Return 0.05% 10% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 11.19% 100% F 88% B+
Risk Adjusted Return 62.95% 98% N/A 84% B
Market Capitalization 39.59B 100% F 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector